These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10229729)

  • 1. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area.
    Spence JD; Malinow MR; Barnett PA; Marian AJ; Freeman D; Hegele RA
    Stroke; 1999 May; 30(5):969-73. PubMed ID: 10229729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis.
    Kawamoto R; Kohara K; Tabara Y; Miki T; Doi T; Tokunaga H; Konishi I
    J Hum Genet; 2001; 46(9):506-10. PubMed ID: 11558898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke.
    Lalouschek W; Aull S; Korninger L; Mannhalter C; Pabinger-Fasching I; Schmid RW; Schnider P; Zeiler K
    J Neurol Sci; 1998 Mar; 155(2):156-62. PubMed ID: 9562260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension.
    Ravera M; Viazzi F; Berruti V; Leoncini G; Zagami P; Bezante GP; Rosatto N; Ravazzolo R; Pontremoli R; Deferrari G
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):371-6. PubMed ID: 11336184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population.
    Inamoto N; Katsuya T; Kokubo Y; Mannami T; Asai T; Baba S; Ogata J; Tomoike H; Ogihara T
    Stroke; 2003 Jul; 34(7):1628-33. PubMed ID: 12775885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
    Taylor LM; DeFrang RD; Harris EJ; Porter JM
    J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area.
    Hegele RA; Ban MR; Anderson CM; Spence JD
    J Investig Med; 2000 May; 48(3):198-202. PubMed ID: 10822900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians.
    Kelemen LE; Anand SS; Hegele RA; Stampfer MJ; Rosner B; Willett WC; Montague PA; Lonn E; Vuksan V; Teo KK; Devanesen S; Yusuf S
    Atherosclerosis; 2004 Oct; 176(2):361-70. PubMed ID: 15380460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L.
    Hackam DG; Peterson JC; Spence JD
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):105-10. PubMed ID: 10678280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
    Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
    Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
    Malinow MR; Nieto FJ; Szklo M; Chambless LE; Bond G
    Circulation; 1993 Apr; 87(4):1107-13. PubMed ID: 8462139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,10-Methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations are genetic determinants of elevated homocysteine.
    Castro R; Rivera I; Ravasco P; Jakobs C; Blom HJ; Camilo ME; de Almeida IT
    QJM; 2003 Apr; 96(4):297-303. PubMed ID: 12651974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-group vitamins, MTHFR C677T polymorphism and carotid intima-media thickness in clinically healthy subjects.
    Liu CS; Chen CH; Chiang HC; Kuo CL; Huang CS; Cheng WL; Wei YH; Chen HW
    Eur J Clin Nutr; 2007 Aug; 61(8):996-1003. PubMed ID: 17228344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.
    Eikelboom JW; Hankey GJ; Anand SS; Lofthouse E; Staples N; Baker RI
    Stroke; 2000 May; 31(5):1069-75. PubMed ID: 10797167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis.
    Bova I; Chapman J; Sylantiev C; Korczyn AD; Bornstein NM
    Stroke; 1999 Oct; 30(10):2180-2. PubMed ID: 10512925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.
    Morita H; Taguchi J; Kurihara H; Kitaoka M; Kaneda H; Kurihara Y; Maemura K; Shindo T; Minamino T; Ohno M; Yamaoki K; Ogasawara K; Aizawa T; Suzuki S; Yazaki Y
    Circulation; 1997 Apr; 95(8):2032-6. PubMed ID: 9133512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
    Yoo JH; Chung CS; Kang SS
    Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.